# Evaluation of the Anticaries Efficacy of Dentifrice Formulations Using an In-situ Model

> **NCT06140758** · NA · COMPLETED · sponsor: **Procter and Gamble** · enrollment: 12 (actual)

## Conditions studied

- Caries

## Interventions

- **DRUG:** Oral-B 1450 ppm Fluoride (1.16% sodium monofluorophosphate) Dentifrice
- **DRUG:** Colgate 1450 ppm Fluoride (1.16% sodium monofluorophosphate)Dentifrice
- **DRUG:** Toms of Maine 0 ppm Fluoride Dentifrice
- **DRUG:** Colgate 1450 ppm Fluoride (1.1% sodium monofluorophosphate) Dentifrice
- **DRUG:** 1500 ppm MFP/CaCO3 1.16% sodium monofluorophosphate) Dentifrice
- **DRUG:** 1100 ppm (0.454% Stannous fluoride) Dentifrice

## Key facts

- **NCT ID:** NCT06140758
- **Lead sponsor:** Procter and Gamble
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-31
- **Primary completion:** 2023-12-11
- **Final completion:** 2023-12-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06140758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06140758, "Evaluation of the Anticaries Efficacy of Dentifrice Formulations Using an In-situ Model". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06140758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*